These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 29915376)

  • 1. A presenilin-1 mutation causes Alzheimer disease without affecting Notch signaling.
    Zhang S; Cai F; Wu Y; Bozorgmehr T; Wang Z; Zhang S; Huang D; Guo J; Shen L; Rankin C; Tang B; Song W
    Mol Psychiatry; 2020 Mar; 25(3):603-613. PubMed ID: 29915376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human Presenilin-1 delivered by AAV9 rescues impaired γ-secretase activity, memory deficits, and neurodegeneration in
    Montenegro P; Chen P; Kang J; Lee SH; Leone S; Shen J
    Proc Natl Acad Sci U S A; 2023 Oct; 120(42):e2306714120. PubMed ID: 37816062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cortical neurodegeneration caused by
    Yan K; Zhang C; Kang J; Montenegro P; Shen J
    Proc Natl Acad Sci U S A; 2024 Aug; 121(34):e2409343121. PubMed ID: 39136994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A presenilin-1 mutation identified in familial Alzheimer disease with cotton wool plaques causes a nearly complete loss of gamma-secretase activity.
    Heilig EA; Xia W; Shen J; Kelleher RJ
    J Biol Chem; 2010 Jul; 285(29):22350-9. PubMed ID: 20460383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genes and mechanisms involved in beta-amyloid generation and Alzheimer's disease.
    Steiner H; Capell A; Leimer U; Haass C
    Eur Arch Psychiatry Clin Neurosci; 1999; 249(6):266-70. PubMed ID: 10653281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Familial Alzheimer's disease mutations in presenilin 1 do not alter levels of the secreted amyloid-beta protein precursor generated by beta-secretase cleavage.
    Zhang C; Browne A; Kim DY; Tanzi RE
    Curr Alzheimer Res; 2010 Feb; 7(1):21-6. PubMed ID: 20205669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of FRM-36143 as a new γ-secretase modulator for the potential treatment of familial Alzheimer's disease.
    Blain JF; Bursavich MG; Freeman EA; Hrdlicka LA; Hodgdon HE; Chen T; Costa DE; Harrison BA; Kapadnis S; Murphy DA; Nolan S; Tu Z; Tang C; Burnett DA; Patzke H; Koenig G
    Alzheimers Res Ther; 2016 Aug; 8(1):34. PubMed ID: 27572246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Familial Alzheimer's disease patient-derived neurons reveal distinct mutation-specific effects on amyloid beta.
    Arber C; Toombs J; Lovejoy C; Ryan NS; Paterson RW; Willumsen N; Gkanatsiou E; Portelius E; Blennow K; Heslegrave A; Schott JM; Hardy J; Lashley T; Fox NC; Zetterberg H; Wray S
    Mol Psychiatry; 2020 Nov; 25(11):2919-2931. PubMed ID: 30980041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knock-in rats with homozygous
    Tambini MD; D'Adamio L
    J Biol Chem; 2020 May; 295(21):7442-7451. PubMed ID: 32265300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presenilin-1 but not amyloid precursor protein mutations present in mouse models of Alzheimer's disease attenuate the response of cultured cells to γ-secretase modulators regardless of their potency and structure.
    Hahn S; Brüning T; Ness J; Czirr E; Baches S; Gijsen H; Korth C; Pietrzik CU; Bulic B; Weggen S
    J Neurochem; 2011 Feb; 116(3):385-95. PubMed ID: 21091478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial Alzheimer disease presenilin-1 mutations alter the active site conformation of γ-secretase.
    Chau DM; Crump CJ; Villa JC; Scheinberg DA; Li YM
    J Biol Chem; 2012 May; 287(21):17288-17296. PubMed ID: 22461631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial Alzheimer's Disease Mutations in PSEN1 Lead to Premature Human Stem Cell Neurogenesis.
    Arber C; Lovejoy C; Harris L; Willumsen N; Alatza A; Casey JM; Lines G; Kerins C; Mueller AK; Zetterberg H; Hardy J; Ryan NS; Fox NC; Lashley T; Wray S
    Cell Rep; 2021 Jan; 34(2):108615. PubMed ID: 33440141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trans-dominant negative effects of pathogenic PSEN1 mutations on γ-secretase activity and Aβ production.
    Heilig EA; Gutti U; Tai T; Shen J; Kelleher RJ
    J Neurosci; 2013 Jul; 33(28):11606-17. PubMed ID: 23843529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developing a Gene Therapy for the Treatment of Autosomal Dominant Alzheimer's Disease.
    Moore B; Sharma A; Goulet M; Suter T; Pelletier C; Hu R; Schaeffer E; Kelleher RJ
    Hum Gene Ther; 2023 Oct; 34(19-20):1049-1063. PubMed ID: 37578141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TRPC6 specifically interacts with APP to inhibit its cleavage by γ-secretase and reduce Aβ production.
    Wang J; Lu R; Yang J; Li H; He Z; Jing N; Wang X; Wang Y
    Nat Commun; 2015 Nov; 6():8876. PubMed ID: 26581893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence For and Against a Pathogenic Role of Reduced γ-Secretase Activity in Familial Alzheimer's Disease.
    Jayne T; Newman M; Verdile G; Sutherland G; Münch G; Musgrave I; Moussavi Nik SH; Lardelli M
    J Alzheimers Dis; 2016 Apr; 52(3):781-99. PubMed ID: 27060961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presenilin-1 mutations of leucine 166 equally affect the generation of the Notch and APP intracellular domains independent of their effect on Abeta 42 production.
    Moehlmann T; Winkler E; Xia X; Edbauer D; Murrell J; Capell A; Kaether C; Zheng H; Ghetti B; Haass C; Steiner H
    Proc Natl Acad Sci U S A; 2002 Jun; 99(12):8025-30. PubMed ID: 12048239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific combinations of presenilins and Aph1s affect the substrate specificity and activity of γ-secretase.
    Yonemura Y; Futai E; Yagishita S; Kaether C; Ishiura S
    Biochem Biophys Res Commun; 2016 Sep; 478(4):1751-7. PubMed ID: 27608597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Important functional role of residue x of the presenilin GxGD protease active site motif for APP substrate cleavage specificity and substrate selectivity of γ-secretase.
    Kretner B; Fukumori A; Kuhn PH; Pérez-Revuelta BI; Lichtenthaler SF; Haass C; Steiner H
    J Neurochem; 2013 Apr; 125(1):144-56. PubMed ID: 23237322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of gamma-secretase reduces beta-amyloid deposition in a transgenic mouse model of Alzheimer's disease.
    Kounnas MZ; Danks AM; Cheng S; Tyree C; Ackerman E; Zhang X; Ahn K; Nguyen P; Comer D; Mao L; Yu C; Pleynet D; Digregorio PJ; Velicelebi G; Stauderman KA; Comer WT; Mobley WC; Li YM; Sisodia SS; Tanzi RE; Wagner SL
    Neuron; 2010 Sep; 67(5):769-80. PubMed ID: 20826309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.